The Department of Health and Human Services today issued a notice of public rulemaking to improve the exchange of patient records used in the treatment of substance use disorder. HHS proposes provisions to implement section 3221 of the Coronavirus Aid, Relief, and Economic Security Act to ensure providers have more complete and timely information when treating patients with SUD, including updating patient consent requirements and aligning disclosure requirements with those under HIPAA regulations.  AHA is among a host of organizations who have pushed for such changes, including one which would enable providers to get a patient’s consent just once to share substance use records for treatment and health care operations. HHS will accept comments for the next 60 days.

Related News Articles

Headline
Commenting today on a proposed rule to improve the exchange of patient records used in the treatment of substance use disorder, AHA said it supports the…
Headline
States, territories, health facilities and tribal organizations can apply through March 27 for up to $525,000 million each for residential treatment programs…
Headline
The share of U.S. overdose deaths involving buprenorphine did not increase after federal agencies allowed clinicians to prescribe the opioid use disorder…
Headline
Nonprofit hospitals and emergency departments, including free standing EDs and Rural Emergency Hospitals, can apply through March 6 for up to $500,000 per year…
Headline
Over 46 million Americans aged 12 and older had a substance use disorder in 2021, 16.5% of the population, only 6% of whom received treatment, according to the…
Headline
The number of health care providers with waivers to prescribe buprenorphine for opioid use disorder increased 19% between October 2021 and September 2022 to…